mGluR2/3 activation of the SIRT1 axis preserves mitochondrial function in diabetic neuropathy

There is a critical need to develop effective treatments for diabetic neuropathy. This study determined if a selective mGluR2/3 receptor agonist prevented or treated experimental diabetic peripheral neuropathy (DPN) through glutamate recycling and improved mitochondrial function